EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSCDRG00005003736
Gene Symbol: RARB
3 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSCDRG00005005534
Gene Symbol: RARG
3 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSCDRG00005022298
Gene Symbol: RXRA
1 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSCDRG00005021632
Gene Symbol: RXRB
1 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSCDRG00005004406
Gene Symbol: RXRG
3 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSCDRG00005008906
Gene Symbol: RPL10A
3 Cross references
226 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCDRG00005018317
Gene Symbol: RPL11
3 Cross references
214 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCDRG00005020034
Gene Symbol: RPL14
1 Cross references
286 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSCDRG00005011453
Gene Symbol: RPL17
3 Cross references
159 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCDRG00005013110
Gene Symbol: RPL18A
2 Cross references
284 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCDRG00005003784
Gene Symbol: RPL19
3 Cross references
243 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCDRG00005016023
Gene Symbol: RPL22
3 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).